Reported May 22, 2013 · Terminated
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences,…
Gilead Sciences, Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Gilead Sciences, Inc. · 333 Lakeside Drive · Foster City, CA · 94404-1147
Is this the product you have?
- Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only
- Manufactured forGilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1
- Lot codes and dates
Lot #: B120217AExp 05/15 - US Distribution
- Amount recalled
- 3,181 vials
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Gilead Sciences, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.